| 摘要 |
<p>The present invention relates to a combination of a selective PDE4 inhibitor , as defined herein, and an adrenergic ss2 receptor agonist for simultaneous, sequential or separate administration by the inhaled route in the treatment of an obstructive airways or other inflammatory disease.</p> |
